NCT00004927View on ClinicalTrials.gov

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

ixabepilone

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

48201

Barbara Ann Karmanos Cancer Institute, Detroit

Sponsors

Lead Sponsor

R-Pharm
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

R-Pharm

INDUSTRY